Doctors Urge Medicare to Deny Coverage for Alzheimer’s Drug With Unproven Efficacy and Safety

Source: Common Dreams

“As Medicare officials grapple with whether to cover Aduhelm (an Alzheimer’s medication approved by federal regulators despite a lack of evidence that the exorbitantly priced and potentially dangerous drug helps patients) many doctors are urging them not to. Medicare plans to issue a preliminary decision this month on whether the federal health insurance program for U.S. residents 65 and older will cover Aduhelm, a monoclonal antibody also known by its scientific name, aducanumab, the New York Times reported Friday. Following a public comment period, the high-stakes coverage decision is expected to be finalized by mid-April. ‘Please, please, please, do not cover this medicine,’ Dr. James Castle, an Illinois neurologist who treats Alzheimer’s patients, wrote last July in the comment section of the Centers for Medicare and Medicaid Services (CMS) website.” (01/01/22)